ATE458495T1 - Therapeutische zubereitung für autoimmune erkrankungen - Google Patents

Therapeutische zubereitung für autoimmune erkrankungen

Info

Publication number
ATE458495T1
ATE458495T1 AT04726221T AT04726221T ATE458495T1 AT E458495 T1 ATE458495 T1 AT E458495T1 AT 04726221 T AT04726221 T AT 04726221T AT 04726221 T AT04726221 T AT 04726221T AT E458495 T1 ATE458495 T1 AT E458495T1
Authority
AT
Austria
Prior art keywords
autoimmune diseases
therapeutic preparation
composition
given
therapeutic
Prior art date
Application number
AT04726221T
Other languages
English (en)
Inventor
Simon Mcewen
Original Assignee
Epidyme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epidyme Ltd filed Critical Epidyme Ltd
Application granted granted Critical
Publication of ATE458495T1 publication Critical patent/ATE458495T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04726221T 2003-04-07 2004-04-07 Therapeutische zubereitung für autoimmune erkrankungen ATE458495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307989.4A GB0307989D0 (en) 2003-04-07 2003-04-07 Therapeutic composition
PCT/GB2004/001562 WO2004089405A1 (en) 2003-04-07 2004-04-07 Therapeutic composition for autoimmune conditions

Publications (1)

Publication Number Publication Date
ATE458495T1 true ATE458495T1 (de) 2010-03-15

Family

ID=9956332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04726221T ATE458495T1 (de) 2003-04-07 2004-04-07 Therapeutische zubereitung für autoimmune erkrankungen

Country Status (10)

Country Link
US (2) US7901676B2 (de)
EP (1) EP1610814B8 (de)
JP (1) JP2006522086A (de)
CN (1) CN1802172A (de)
AT (1) ATE458495T1 (de)
CA (1) CA2521602A1 (de)
DE (1) DE602004025683D1 (de)
GB (2) GB0307989D0 (de)
MX (1) MXPA05010790A (de)
WO (1) WO2004089405A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
ES2487513T3 (es) * 2007-12-12 2014-08-21 Dacy Tech Pty Ltd Composición nutracéutica y métodos de uso
AU2008336268B2 (en) * 2007-12-12 2014-06-12 Dacy Tech Pty Ltd Nutraceutical composition and methods of use
US10376550B2 (en) 2007-12-12 2019-08-13 Dacy Tech Pty Ltd. Nutraceutical composition and methods of use
ITMI20080357A1 (it) * 2008-03-04 2009-09-05 Sarm Allergeni Srl Proteina da haliotis midae e suo uso come agente immunoterapico
SG10201601905RA (en) * 2016-03-11 2017-10-30 Kah Meng Lim Extract And Method of Extraction
CN115629048B (zh) * 2022-10-26 2025-12-09 上海执诚生物科技有限公司 一种抗肝素干扰的丙氨酸氨基转移酶检测试剂盒及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2620649C3 (de) * 1976-05-11 1980-11-06 Behringwerke Ag, 3550 Marburg Immunologisches Adjuvans
US5268463A (en) * 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
GB8713906D0 (en) 1987-06-15 1987-07-22 Mcewen L M Beta-glucuronidase containing compositions
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
DE4125400C2 (de) * 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
DE19828450A1 (de) * 1998-06-26 1999-12-30 Hassan Jomaa Bisphosphonsäuren und deren Derivate enthaltende Arzneimittel zur Prophylaxe und zur Behandlung von Autoimmunkrankheiten sowie von Allergien
KR20010085901A (ko) * 1998-10-07 2001-09-07 릴리 엠 씨즐러 스피허, 아네뜨 워너 식물에서의 치료학적 활성 단백질
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
US6649172B2 (en) * 2000-03-17 2003-11-18 Corixa Corporation Amphipathic aldehydes and their uses as adjuvants and immunoeffectors
EP1228767A1 (de) 2001-01-31 2002-08-07 S.A.R.M. S.r.l. Verwendung der beta-Glukuronidase zur Behandlung von Immun- oder allergischen Krankheiten
CA2445486A1 (en) * 2001-03-19 2002-09-26 Iomai Corporation Patch for transcutaneous immunization
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
EP1453539B1 (de) * 2001-12-05 2008-11-19 Circassia Limited Immunotherapeutische methoden und systeme
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
US9549959B2 (en) * 2006-09-15 2017-01-24 I Did It, Inc. Animal chew toy containing solid food

Also Published As

Publication number Publication date
EP1610814A1 (de) 2006-01-04
GB0307989D0 (en) 2003-05-14
CA2521602A1 (en) 2004-10-21
GB2400556B (en) 2005-10-19
GB0407828D0 (en) 2004-05-12
EP1610814B1 (de) 2010-02-24
US7901676B2 (en) 2011-03-08
JP2006522086A (ja) 2006-09-28
EP1610814B8 (de) 2010-06-02
MXPA05010790A (es) 2006-07-10
US20040228850A1 (en) 2004-11-18
HK1087328A1 (en) 2006-10-13
GB2400556A (en) 2004-10-20
US20110135624A1 (en) 2011-06-09
DE602004025683D1 (de) 2010-04-08
CN1802172A (zh) 2006-07-12
WO2004089405A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
ATE312635T1 (de) Ventilanordnung
MX2010004074A (es) Combinacion 059.
WO2005049000A3 (en) Treatment of phenylketonurias with bh4
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EP2298862A3 (de) Mesenchymale Stammzellen und deren Verwendungen
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
EA200601107A1 (ru) Композиции, получаемые из морских растений, для обеспечения питания для старческой и поврежденной окружающей средой кожи
EP1670450A4 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
MA28106A1 (fr) Compositions immunogenes
MX2025002705A (es) Isoquinolonas como inhibidores de pi3k
PT1572178E (pt) Tratamento de mastalgia com 4-hidroxi-tamoxifeno
ATE458495T1 (de) Therapeutische zubereitung für autoimmune erkrankungen
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
WO2004043373A3 (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
ATE556134T1 (de) Mesenchymstammzellen und verwendungendafür
MXPA04007491A (es) Tratamiento profilactico y terapeutico de infecciones y otras enfermedades con compuestos inmunoefectores.
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
EA200500765A1 (ru) Применение докозагексановой кислоты в качестве активного вещества для лечения липодистрофии
PL1599211T3 (pl) Zastosowanie izorhamnetyny do leczenia nastrojów i chorób depresyjnych
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
EA200870108A1 (ru) Мутанты фсг
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
IL175019A0 (en) Cxcl8 antagonists, their preparation and use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties